Preclinical News and Research

RSS
TJU researchers to investigate Cu-64 imaging agent for prostate cancer

TJU researchers to investigate Cu-64 imaging agent for prostate cancer

NeuroSigma Subsidiary sees potential for Thin-Film Nitinol in next-generation flow-diverting stents for treating intracranial aneurysms

NeuroSigma Subsidiary sees potential for Thin-Film Nitinol in next-generation flow-diverting stents for treating intracranial aneurysms

Hitting the target: IntelliCap provides reliable and accurate regional drug delivery

Hitting the target: IntelliCap provides reliable and accurate regional drug delivery

AxioMed’s Freedom Cervical Disc receives CE Mark approval

AxioMed’s Freedom Cervical Disc receives CE Mark approval

Cyclophosphamide drug makes the bone marrow more tumor-friendly

Cyclophosphamide drug makes the bone marrow more tumor-friendly

InVivo Therapeutics reports net income of $3,150,000 for first quarter 2012

InVivo Therapeutics reports net income of $3,150,000 for first quarter 2012

Researchers identify new biomarker and therapeutic target for pancreatic cancer

Researchers identify new biomarker and therapeutic target for pancreatic cancer

Phase II trial to examine effects of resveratrol on individuals with mild to moderate dementia

Phase II trial to examine effects of resveratrol on individuals with mild to moderate dementia

Lung cancer molecular subtypes correlate with genetic alterations, patient's response to therapy

Lung cancer molecular subtypes correlate with genetic alterations, patient's response to therapy

Arno AR-42 for neurofibromatosis type 2 receives EMA orphan-drug designation

Arno AR-42 for neurofibromatosis type 2 receives EMA orphan-drug designation

New combination therapy offers potential lifetime cure for advanced type 1 diabetes

New combination therapy offers potential lifetime cure for advanced type 1 diabetes

PET imaging for sudden cardiac arrest can identify candidates for ICDs

PET imaging for sudden cardiac arrest can identify candidates for ICDs

Final results from Alnylam’s ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Final results from Alnylam’s ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Preclinical evidence demonstrates link between psoriasis and cardiovascular disease

Preclinical evidence demonstrates link between psoriasis and cardiovascular disease

Cardionovum to introduce two DEB dilatation catheter product families

Cardionovum to introduce two DEB dilatation catheter product families

Discovery Labs reports data from SURFAXIN preclinical study on RDS

Discovery Labs reports data from SURFAXIN preclinical study on RDS

IDRI, Aeras partner to develop new TB vaccine candidate

IDRI, Aeras partner to develop new TB vaccine candidate

Inovio first quarter total revenue decreases to $1.7 million

Inovio first quarter total revenue decreases to $1.7 million

C3BS’s C-Cath Injection Catheter receives CE Marking

C3BS’s C-Cath Injection Catheter receives CE Marking

Bumped kinase inhibitors may control malaria

Bumped kinase inhibitors may control malaria

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.